Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

Racial Comparisons in Timeliness of Colon Cancer Treatment in an Equal-Access Health System.

Eaglehouse YL, Georg MW, Shriver CD, Zhu K.

J Natl Cancer Inst. 2019 Jul 4. pii: djz135. doi: 10.1093/jnci/djz135. [Epub ahead of print]

PMID:
31271431
2.

Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome.

Plasterer C, Tsaih SW, Peck AR, Chervoneva I, O'Meara C, Sun Y, Lemke A, Murphy D, Smith J, Ran S, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Bergom C, Joshi A, Auer P, Prokop J, Rui H, Flister MJ.

Breast Cancer Res Treat. 2019 Jun 4. doi: 10.1007/s10549-019-05307-8. [Epub ahead of print]

PMID:
31165373
3.

PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B.

Raj-Kumar PK, Liu J, Hooke JA, Kovatich AJ, Kvecher L, Shriver CD, Hu H.

Sci Rep. 2019 May 28;9(1):7956. doi: 10.1038/s41598-019-44339-4.

4.

Metachronous Contralateral Male Breast Cancer: Case Report and Literature Review.

O'Leary TR, Shriver CD, Wind G.

Mil Med. 2019 Apr 2. pii: usz049. doi: 10.1093/milmed/usz049. [Epub ahead of print]

PMID:
30938815
5.

Serum Biomarkers for Racial Disparities in Breast Cancer Progression.

Srivastava M, Eidelman O, Craig J, Starr J, Kvecher L, Liu J, Hueman M, Pollard HB, Hu H, Shriver CD.

Mil Med. 2019 Mar 1;184(Suppl 1):652-657. doi: 10.1093/milmed/usy417.

PMID:
30901475
6.

Cost-Efficiency of Breast Cancer Care in the US Military Health System: An Economic Evaluation in Direct and Purchased Care.

Eaglehouse YL, Georg MW, Richard P, Shriver CD, Zhu K.

Mil Med. 2019 Mar 6. pii: usz025. doi: 10.1093/milmed/usz025. [Epub ahead of print]

PMID:
30839064
7.

From Discovery to Practice and Survivorship: Building a National Real-World Data Learning Healthcare Framework for Military and Veteran Cancer Patients.

Lee JSH, Darcy KM, Hu H, Casablanca Y, Conrads TP, Dalgard CL, Freymann JB, Hanlon SE, Huang GD, Kvecher L, Maxwell GL, Meng F, Moncur JT, Turner C, Wells JM, Wilkerson MD, Zhu K, Ramoni RB, Shriver CD.

Clin Pharmacol Ther. 2019 Jul;106(1):52-57. doi: 10.1002/cpt.1425. Epub 2019 Apr 29. No abstract available.

8.

Racial Differences in Time to Breast Cancer Surgery and Overall Survival in the US Military Health System.

Eaglehouse YL, Georg MW, Shriver CD, Zhu K.

JAMA Surg. 2019 Jan 23:e185113. doi: 10.1001/jamasurg.2018.5113. [Epub ahead of print] Erratum in: JAMA Surg. 2019 Mar 1;154(3):272.

PMID:
30673075
9.

Race and renal cell carcinoma stage at diagnosis: an analysis of the Surveillance, Epidemiology, and End Results data.

Lin J, Kamamia C, Shriver CD, Zhu K.

Eur J Cancer Prev. 2019 Jul;28(4):350-354. doi: 10.1097/CEJ.0000000000000484.

PMID:
30376467
10.

Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.

Tran TH, Utama FE, Sato T, Peck AR, Langenheim JF, Udhane SS, Sun Y, Liu C, Girondo MA, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Palazzo JP, Bibbo M, Auer PW, Flister MJ, Hyslop T, Mitchell EP, Chervoneva I, Rui H.

Clin Cancer Res. 2018 Dec 15;24(24):6355-6366. doi: 10.1158/1078-0432.CCR-17-3280. Epub 2018 Aug 10.

PMID:
30097435
11.

Deployment and Smokeless Tobacco Use Among Active Duty Service Members in the U.S. Military.

Lin J, Zhu K, Soliván-Ortiz AM, Larsen SL, Schneid TR, Shriver CD, Lee S.

Mil Med. 2019 Mar 1;184(3-4):e183-e190. doi: 10.1093/milmed/usy186.

PMID:
30085231
12.

Smokeless Tobacco Use and Related Factors: A Study in the US Military Population.

Lin J, Zhu K, Soliván-Ortiz AM, Larsen SL, Schneid TR, Shriver CD, Lee S.

Am J Health Behav. 2018 Jul 1;42(4):102-117. doi: 10.5993/AJHB.42.4.10.

PMID:
29973315
13.

Organochlorine pesticide residues in human breast tissue and their relationships with clinical and pathological characteristics of breast cancer.

Ellsworth RE, Kostyniak PJ, Chi LH, Shriver CD, Costantino NS, Ellsworth DL.

Environ Toxicol. 2018 Jun 19. doi: 10.1002/tox.22573. [Epub ahead of print]

PMID:
29923341
14.

The Impact of Hormonal Contraceptives on Breast Cancer Pathology.

Dorchak JA, Maria S, Guarinoni JL, Duensing A, Somiari S, Cavanaugh J, Deyarmin B, Hu H, Iida J, Shriver CD, Witt-Enderby PA.

Horm Cancer. 2018 Aug;9(4):240-253. doi: 10.1007/s12672-018-0332-y. Epub 2018 Apr 23.

PMID:
29687205
15.

Costs for Breast Cancer Care in the Military Health System: An Analysis by Benefit Type and Care Source.

Eaglehouse YL, Manjelievskaia J, Shao S, Brown D, Hofmann K, Richard P, Shriver CD, Zhu K.

Mil Med. 2018 Nov 1;183(11-12):e500-e508. doi: 10.1093/milmed/usy052.

PMID:
29660010
16.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.

Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, Omberg L, Wolf DM, Shriver CD, Thorsson V; Cancer Genome Atlas Research Network, Hu H.

Cell. 2018 Apr 5;173(2):400-416.e11. doi: 10.1016/j.cell.2018.02.052.

17.

Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types.

Ge Z, Leighton JS, Wang Y, Peng X, Chen Z, Chen H, Sun Y, Yao F, Li J, Zhang H, Liu J, Shriver CD, Hu H; Cancer Genome Atlas Research Network, Piwnica-Worms H, Ma L, Liang H.

Cell Rep. 2018 Apr 3;23(1):213-226.e3. doi: 10.1016/j.celrep.2018.03.047.

18.

Lung, Breast, and Prostate Cancer Patients with Unknown Ethnicity in US Department of Defense Cancer Registry Data: Comparisons to Patients with Known Ethnicity.

Lin J, Kamamia C, Shao S, Brown D, Rockswold PD, Butts E, Shriver CD, Zhu K.

J Registry Manag. 2017 Spring;44(1):17-29.

PMID:
29595941
19.

Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER Population.

Lin J, Kamamia C, Brown D, Shao S, McGlynn KA, Nations JA, Carter CA, Shriver CD, Zhu K.

Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):673-679. doi: 10.1158/1055-9965.EPI-17-0822. Epub 2018 Mar 12.

20.

The continuum of breast cancer care and outcomes in the U.S. Military Health System: an analysis by benefit type and care source.

Eaglehouse YL, Shao S, Chan W, Brown D, Manjelievskaia J, Shriver CD, Zhu K.

J Cancer Surviv. 2018 Jun;12(3):407-416. doi: 10.1007/s11764-018-0680-1. Epub 2018 Feb 17.

PMID:
29455447
21.

Breast Cancer Treatment and Survival Among Department of Defense Beneficiaries: An Analysis by Benefit Type and Care Source.

Manjelievskaia J, Brown D, Shao S, Hofmann K, Shriver CD, Zhu K.

Mil Med. 2018 Mar 1;183(3-4):e186-e195. doi: 10.1093/milmed/usx031.

PMID:
29365174
22.

Analysis of breast cancer in young women in the Department of Defense (DOD) database.

Zimmer AS, Zhu K, Steeg PS, Wu A, Gatti-Mays ME, Soltani S, Perkins JG, Shao S, Brown D, Georg M, Hu H, Shriver CD, Lipkowitz S.

Breast Cancer Res Treat. 2018 Apr;168(2):501-511. doi: 10.1007/s10549-017-4615-8. Epub 2017 Dec 15.

23.

Diabetes and Overall Survival among Breast Cancer Patients in the U.S. Military Health System.

Shao S, Gill AA, Zahm SH, Jatoi I, Shriver CD, McGlynn KA, Zhu K.

Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):50-57. doi: 10.1158/1055-9965.EPI-17-0439. Epub 2017 Nov 2.

24.

Comparative Survival Analysis of Invasive Breast Cancer Patients Treated by a U.S. Military Medical Center and Matched Patients From the U.S. General Population.

Ru Y, Liu J, Fantacone-Campbell JL, Zhu K, Kovatich AJ, Hooke JA, Kvecher L, Deyarmin B, Kovatich AW, Cammarata F, Hueman MT, Rui H, Mural RJ, Shriver CD, Hu H.

Mil Med. 2017 Nov;182(11):e1851-e1858. doi: 10.7205/MILMED-D-17-00097.

PMID:
29087852
25.

Midkine and pleiotrophin concentrations in needle biopsies of breast and lung masses.

Giamanco NM, Jee YH, Wellstein A, Shriver CD, Summers TA, Baron J.

Cancer Biomark. 2017 Sep 7;20(3):299-307. doi: 10.3233/CBM-170145.

26.

Impact of age at diagnosis on racial disparities in endometrial cancer patients.

Tarney CM, Tian C, Wang G, Dubil EA, Bateman NW, Chan JK, Elshaikh MA, Cote ML, Schildkraut JM, Shriver CD, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM.

Gynecol Oncol. 2018 Apr;149(1):12-21. doi: 10.1016/j.ygyno.2017.07.145. Epub 2017 Aug 8.

PMID:
28800945
27.

CDC Screening Recommendation for Baby Boomers and Hepatitis C Virus Testing in the US Military Health System.

Manjelievskaia J, Brown D, Shriver CD, Zhu K.

Public Health Rep. 2017 Sep/Oct;132(5):579-584. doi: 10.1177/0033354917719446. Epub 2017 Aug 2.

28.

Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients.

Bateman NW, Dubil EA, Wang G, Hood BL, Oliver JM, Litzi TA, Gist GD, Mitchell DA, Blanton B, Phippen NT, Tian C, Zahn CM, Cohn DE, Havrilesky LJ, Berchuck A, Shriver CD, Darcy KM, Hamilton CA, Conrads TP, Maxwell GL.

Cancer. 2017 Oct 15;123(20):4004-4012. doi: 10.1002/cncr.30813. Epub 2017 Jun 27.

29.

Use of Adjuvant Chemotherapy After Surgery in Patients With Colon Cancer-Reply.

Zhu K, Manjelievskaia J, Shriver CD.

JAMA Surg. 2017 Sep 1;152(9):895-896. doi: 10.1001/jamasurg.2017.1618. No abstract available.

PMID:
28614584
30.

Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer.

Rummel SK, Lovejoy L, Shriver CD, Ellsworth RE.

Breast Cancer Res Treat. 2017 Aug;164(3):593-601. doi: 10.1007/s10549-017-4291-8. Epub 2017 May 13.

PMID:
28503720
31.

Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.

Huo D, Hu H, Rhie SK, Gamazon ER, Cherniack AD, Liu J, Yoshimatsu TF, Pitt JJ, Hoadley KA, Troester M, Ru Y, Lichtenberg T, Sturtz LA, Shelley CS, Benz CC, Mills GB, Laird PW, Shriver CD, Perou CM, Olopade OI.

JAMA Oncol. 2017 Dec 1;3(12):1654-1662. doi: 10.1001/jamaoncol.2017.0595.

32.

Breast Cancer Metastasis to the Axillary Lymph Nodes: Are Changes to the Lymph Node "Soil" Localized or Systemic?

Blackburn HL, Ellsworth DL, Shriver CD, Ellsworth RE.

Breast Cancer (Auckl). 2017 Feb 10;11:1178223417691246. doi: 10.1177/1178223417691246. eCollection 2017.

33.

Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis.

Ellsworth DL, Blackburn HL, Shriver CD, Rabizadeh S, Soon-Shiong P, Ellsworth RE.

Clin Transl Med. 2017 Dec;6(1):15. doi: 10.1186/s40169-017-0145-6. Epub 2017 Apr 12. Review.

34.

Metformin use and survival after non-small cell lung cancer: A cohort study in the US Military health system.

Lin J, Gill A, Zahm SH, Carter CA, Shriver CD, Nations JA, Anderson WF, McGlynn KA, Zhu K.

Int J Cancer. 2017 Jul 15;141(2):254-263. doi: 10.1002/ijc.30724. Epub 2017 May 4.

35.

Benefit Type and Care Source in Relation to Mammography Screening and Breast Cancer Stage at Diagnosis Among DoD Beneficiaries.

Manjelievskaia J, Brown D, Shao S, Hofmann K, Shriver CD, Zhu K.

Mil Med. 2017 Mar;182(3):e1782-e1789. doi: 10.7205/MILMED-D-16-00249.

PMID:
28290959
37.

Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Colon Cancer.

Manjelievskaia J, Brown D, McGlynn KA, Anderson W, Shriver CD, Zhu K.

JAMA Surg. 2017 May 1;152(5):452-459. doi: 10.1001/jamasurg.2016.5050.

38.

Molecular heterogeneity in breast cancer: State of the science and implications for patient care.

Ellsworth RE, Blackburn HL, Shriver CD, Soon-Shiong P, Ellsworth DL.

Semin Cell Dev Biol. 2017 Apr;64:65-72. doi: 10.1016/j.semcdb.2016.08.025. Epub 2016 Aug 26. Review.

39.

The Impact of Preexisting Mental Health Disorders on the Diagnosis, Treatment, and Survival among Lung Cancer Patients in the U.S. Military Health System.

Lin J, McGlynn KA, Carter CA, Nations JA, Anderson WF, Shriver CD, Zhu K.

Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1564-1571. Epub 2016 Aug 26.

40.

Outcome Disparities in African American Compared with European American Women with ER+HER2- Tumors Treated within an Equal-Access Health Care System.

Costantino NS, Freeman B, Shriver CD, Ellsworth RE.

Ethn Dis. 2016 Jul 21;26(3):407-16. doi: 10.18865/ed.26.3.407.

41.

Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.

Peck AR, Girondo MA, Liu C, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Freydin B, Hyslop T, Chervoneva I, Rui H.

Mod Pathol. 2016 Oct;29(10):1143-54. doi: 10.1038/modpathol.2016.112. Epub 2016 Jun 17.

42.

NSQIP Analysis: Increased Immediate Reconstruction in the Treatment of Breast Cancer.

Sabino J, Lucas DJ, Shriver CD, Vertrees AE, Valerio IL, Singh DP.

Am Surg. 2016 Jun;82(6):540-5.

PMID:
27305887
43.

Overall and recurrence-free survival among black and white bladder cancer patients in an equal-access health system.

Schinkel JK, Shao S, Zahm SH, McGlynn KA, Shriver CD, Zhu K.

Cancer Epidemiol. 2016 Jun;42:154-8. doi: 10.1016/j.canep.2016.04.012. Epub 2016 May 6.

44.

Effect of obesity on molecular characteristics of invasive breast tumors: gene expression analysis in a large cohort of female patients.

Toro AL, Costantino NS, Shriver CD, Ellsworth DL, Ellsworth RE.

BMC Obes. 2016 Apr 29;3:22. doi: 10.1186/s40608-016-0103-7. eCollection 2016.

45.

Trends in use of contralateral prophylactic mastectomy by racial/ethnic group and ER/PR status among patients with breast cancer: A SEER population-based study.

Brown D, Shao S, Jatoi I, Shriver CD, Zhu K.

Cancer Epidemiol. 2016 Jun;42:24-31. doi: 10.1016/j.canep.2016.02.011. Epub 2016 Mar 18.

PMID:
26999400
46.

Inhibition of cancer cell growth by ruthenium complexes.

Iida J, Bell-Loncella ET, Purazo ML, Lu Y, Dorchak J, Clancy R, Slavik J, Cutler ML, Shriver CD.

J Transl Med. 2016 Feb 12;14:48. doi: 10.1186/s12967-016-0797-9.

47.
48.

A Prognostic Model to Predict Mortality among Non-Small-Cell Lung Cancer Patients in the U.S. Military Health System.

Lin J, Carter CA, McGlynn KA, Zahm SH, Nations JA, Anderson WF, Shriver CD, Zhu K.

J Thorac Oncol. 2015 Dec;10(12):1694-702. doi: 10.1097/JTO.0000000000000691.

49.

Renal Cancer Patients with Unknown Ethnicity in Cancer Registry Data: Comparisons to Patients with Known Ethnicity.

Lin J, Butts E, Rockswold PD, Shriver CD, Zhu K.

J Registry Manag. 2015 Summer;42(2):62-9.

PMID:
26360107
50.

Tumour location within the breast: Does tumour site have prognostic ability?

Rummel S, Hueman MT, Costantino N, Shriver CD, Ellsworth RE.

Ecancermedicalscience. 2015 Jul 13;9:552. doi: 10.3332/ecancer.2015.552. eCollection 2015.

Supplemental Content

Loading ...
Support Center